Delivery Order SPE2DB22D2007-SPE2DB24FJ1WK
Award Date 4/24/24
Potential Completion Date 5/15/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The $11,031.48 firm fixed price contract has a completion date of March 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a $7,513.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,259 units of the pharmaceutical product HYPERRAB 300 UNIT/ML VIAL 5ML. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will provide these critical medical supplies to support government healthcare programs. The contract has an ultimate completion date of August 16,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The delivery order is valued at $3,756.72 and has a firm fixed-price pricing structure. The ultimate completion date for this contract is August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,466.28 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide pharmaceutical products, including HYPERRAB 300 UNIT/ML VIALML. This delivery order has a performance period through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) also awarded by DLA, with a potential value of $999,999,999.00 and a performance...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,721.90 firm fixed-price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIALML, a medical product, with a period of performance through November 12, 2024. The contract is an indefinite delivery vehicle and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This contract award to Amerisourcebergen Drug Corporation (Amerisourcebergen) is a Delivery Order with a Firm Fixed Price valued at $33,736.80. The award was made by the Defense Logistics Agency (DLA) on August 11, 2024, with an ultimate completion date of August 30, 2024. The contract is for the supply of 4,565,415,136 units of the pharmaceutical product HYPERRAB 300 UNIT/ML VIAL 3ML. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,067.31 Firm Fixed Price Delivery Order contract is for the provision of HYPERRAB 300UNIT/ML 1S medical supplies. The contract has an ultimate completion date of July 14, 2025 and was awarded on June 13, 2025 without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a ceiling value of $7,163.24 and is a firm fixed price contract. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The company holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,004.32 firm fixed price delivery order provides for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML medical supplies. The $3,886.54 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...